ID   HST2_YEAST              Reviewed;         357 AA.
AC   P53686; D6W3Z7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   18-JUN-2025, entry version 199.
DE   RecName: Full=NAD-dependent protein deacetylase HST2;
DE            EC=2.3.1.286 {ECO:0000255|PROSITE-ProRule:PRU00236};
DE   AltName: Full=Homologous to SIR2 protein 2;
DE   AltName: Full=Regulatory protein SIR2 homolog 2;
GN   Name=HST2; OrderedLocusNames=YPL015C; ORFNames=LPA2C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=S288c / YPH1;
RX   PubMed=7498786; DOI=10.1101/gad.9.23.2888;
RA   Brachmann C.B., Sherman J.M., Devine S.E., Cameron E.E., Pillus L.,
RA   Boeke J.D.;
RT   "The SIR2 gene family, conserved from bacteria to humans, functions in
RT   silencing, cell cycle progression, and chromosome stability.";
RL   Genes Dev. 9:2888-2902(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169875; DOI=10.1038/387s103;
RA   Bussey H., Storms R.K., Ahmed A., Albermann K., Allen E., Ansorge W.,
RA   Araujo R., Aparicio A., Barrell B.G., Badcock K., Benes V., Botstein D.,
RA   Bowman S., Brueckner M., Carpenter J., Cherry J.M., Chung E.,
RA   Churcher C.M., Coster F., Davis K., Davis R.W., Dietrich F.S., Delius H.,
RA   DiPaolo T., Dubois E., Duesterhoeft A., Duncan M., Floeth M., Fortin N.,
RA   Friesen J.D., Fritz C., Goffeau A., Hall J., Hebling U., Heumann K.,
RA   Hilbert H., Hillier L.W., Hunicke-Smith S., Hyman R.W., Johnston M.,
RA   Kalman S., Kleine K., Komp C., Kurdi O., Lashkari D., Lew H., Lin A.,
RA   Lin D., Louis E.J., Marathe R., Messenguy F., Mewes H.-W., Mirtipati S.,
RA   Moestl D., Mueller-Auer S., Namath A., Nentwich U., Oefner P., Pearson D.,
RA   Petel F.X., Pohl T.M., Purnelle B., Rajandream M.A., Rechmann S.,
RA   Rieger M., Riles L., Roberts D., Schaefer M., Scharfe M., Scherens B.,
RA   Schramm S., Schroeder M., Sdicu A.-M., Tettelin H., Urrestarazu L.A.,
RA   Ushinsky S., Vierendeels F., Vissers S., Voss H., Walsh S.V., Wambutt R.,
RA   Wang Y., Wedler E., Wedler H., Winnett E., Zhong W.-W., Zollner A.,
RA   Vo D.H., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI.";
RL   Nature 387:103-105(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   FUNCTION.
RX   PubMed=10811920; DOI=10.1073/pnas.110148297;
RA   Landry J., Sutton A., Tafrov S.T., Heller R.C., Stebbins J., Pillus L.,
RA   Sternglanz R.;
RT   "The silencing protein SIR2 and its homologs are NAD-dependent protein
RT   deacetylases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5807-5811(2000).
RN   [6]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11106374; DOI=10.1073/pnas.250422697;
RA   Tanner K.G., Landry J., Sternglanz R., Denu J.M.;
RT   "Silent information regulator 2 family of NAD- dependent histone/protein
RT   deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14178-14182(2000).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11226170; DOI=10.1093/emboj/20.1.197;
RA   Perrod S., Cockell M.M., Laroche T., Renauld H., Ducrest A.L., Bonnard C.,
RA   Gasser S.M.;
RT   "A cytosolic NAD-dependent deacetylase, Hst2p, can modulate nucleolar and
RT   telomeric silencing in yeast.";
RL   EMBO J. 20:197-209(2001).
RN   [8]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [9]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [10]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15274642; DOI=10.1021/bi049592e;
RA   Borra M.T., Langer M.R., Slama J.T., Denu J.M.;
RT   "Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-
RT   dependent histone/protein deacetylases.";
RL   Biochemistry 43:9877-9887(2004).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17110954; DOI=10.1038/sj.embor.7400829;
RA   Wilson J.M., Le V.Q., Zimmerman C., Marmorstein R., Pillus L.;
RT   "Nuclear export modulates the cytoplasmic Sir2 homologue Hst2.";
RL   EMBO Rep. 7:1247-1251(2006).
RN   [12]
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16520376; DOI=10.1074/jbc.m511482200;
RA   Khan A.N., Lewis P.N.;
RT   "Use of substrate analogs and mutagenesis to study substrate binding and
RT   catalysis in the Sir2 family of NAD-dependent protein deacetylases.";
RL   J. Biol. Chem. 281:11702-11711(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [14]
RP   ACTIVE SITE.
RX   PubMed=20726530; DOI=10.1021/jp1054183;
RA   Liang Z., Shi T., Ouyang S., Li H., Yu K., Zhu W., Luo C., Jiang H.;
RT   "Investigation of the catalytic mechanism of Sir2 enzyme with QM/MM
RT   approach: SN1 vs SN2?";
RL   J. Phys. Chem. B 114:11927-11933(2010).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH PEPTIDE SUBSTRATE;
RP   ZINC AND NAD.
RX   PubMed=14502267; DOI=10.1038/nsb978;
RA   Zhao K., Chai X., Clements A., Marmorstein R.;
RT   "Structure and autoregulation of the yeast Hst2 homolog of Sir2.";
RL   Nat. Struct. Biol. 10:864-871(2003).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 5-293 IN COMPLEX WITH SUBSTRATE
RP   ANALOG; PEPTIDE SUBSTRATE AND ZINC, AND SUBUNIT.
RX   PubMed=14604530; DOI=10.1016/j.str.2003.09.016;
RA   Zhao K., Chai X., Marmorstein R.;
RT   "Structure of the yeast Hst2 protein deacetylase in ternary complex with
RT   2'-O-acetyl ADP ribose and histone peptide.";
RL   Structure 11:1403-1411(2003).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 1-294 IN COMPLEX WITH PEPTIDE
RP   SUBSTRATE; ZINC AND NAD.
RX   PubMed=15150415; DOI=10.1073/pnas.0401057101;
RA   Zhao K., Harshaw R., Chai X., Marmorstein R.;
RT   "Structural basis for nicotinamide cleavage and ADP-ribose transfer by
RT   NAD(+)-dependent Sir2 histone/protein deacetylases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8563-8568(2004).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1-294 IN COMPLEX WITH PEPTIDE
RP   SUBSTRATE; NICOTINAMIDE AND ZINC, MUTAGENESIS OF 117, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17289592; DOI=10.1016/j.molcel.2006.12.022;
RA   Sanders B.D., Zhao K., Slama J.T., Marmorstein R.;
RT   "Structural basis for nicotinamide inhibition and base exchange in Sir2
RT   enzymes.";
RL   Mol. Cell 25:463-472(2007).
CC   -!- FUNCTION: NAD-dependent histone deacetylase that is involved in nuclear
CC       silencing events. Derepresses subtelomeric silencing and increases
CC       repression in nucleolar (rDNA) silencing. Its function is negatively
CC       regulated by active nuclear export. {ECO:0000269|PubMed:10811920,
CC       ECO:0000269|PubMed:11106374, ECO:0000269|PubMed:11226170,
CC       ECO:0000269|PubMed:15274642, ECO:0000269|PubMed:17110954}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-acetyl-L-lysyl-[protein] + NAD(+) + H2O = 2''-O-acetyl-
CC         ADP-D-ribose + nicotinamide + L-lysyl-[protein];
CC         Xref=Rhea:RHEA:43636, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10731,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:17154, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:61930, ChEBI:CHEBI:83767;
CC         EC=2.3.1.286; Evidence={ECO:0000255|PROSITE-ProRule:PRU00236,
CC         ECO:0000269|PubMed:16520376};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion per subunit.;
CC   -!- ACTIVITY REGULATION: Inhibited by ADP-ribose and nicotinamide.
CC       {ECO:0000269|PubMed:16520376}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.2 uM for NAD(+) {ECO:0000269|PubMed:11106374,
CC         ECO:0000269|PubMed:15274642, ECO:0000269|PubMed:16520376,
CC         ECO:0000269|PubMed:17289592};
CC         KM=0.92 uM for acetylated poly-L-lysine {ECO:0000269|PubMed:11106374,
CC         ECO:0000269|PubMed:15274642, ECO:0000269|PubMed:16520376,
CC         ECO:0000269|PubMed:17289592};
CC         KM=0.5 uM for a synthetic histone H3K14 acetyllysine peptide
CC         {ECO:0000269|PubMed:11106374, ECO:0000269|PubMed:15274642,
CC         ECO:0000269|PubMed:16520376, ECO:0000269|PubMed:17289592};
CC   -!- SUBUNIT: Homotrimer. Monomer. Homotrimeric in its unliganded state.
CC       Undergoes a trimer-monomer transition upon acetyl-lysine substrate
CC       binding. {ECO:0000269|PubMed:14502267, ECO:0000269|PubMed:14604530,
CC       ECO:0000269|PubMed:15150415, ECO:0000269|PubMed:17289592}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Shuttles between the
CC       nucleus and cytoplasm, but is largely cytoplasmic owing to efficient
CC       nuclear export. Nuclear exclusion is mediated by the exportin CRM1.
CC   -!- MISCELLANEOUS: Present with 5260 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the sirtuin family. Class I subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U39063; AAA81035.1; -; Genomic_DNA.
DR   EMBL; U33335; AAB68090.1; -; Genomic_DNA.
DR   EMBL; AY693204; AAT93223.1; -; Genomic_DNA.
DR   EMBL; BK006949; DAA11413.1; -; Genomic_DNA.
DR   PIR; S59678; S59678.
DR   RefSeq; NP_015310.1; NM_001183829.1.
DR   PDB; 1Q14; X-ray; 2.50 A; A=1-357.
DR   PDB; 1Q17; X-ray; 2.70 A; A/B/C=1-294.
DR   PDB; 1Q1A; X-ray; 1.50 A; A=5-293.
DR   PDB; 1SZC; X-ray; 1.75 A; A=1-294.
DR   PDB; 1SZD; X-ray; 1.50 A; A=1-294.
DR   PDB; 2OD2; X-ray; 2.00 A; A=1-294.
DR   PDB; 2OD7; X-ray; 2.00 A; A=1-294.
DR   PDB; 2OD9; X-ray; 2.05 A; A=1-294.
DR   PDB; 2QQF; X-ray; 2.00 A; A=1-294.
DR   PDB; 2QQG; X-ray; 2.05 A; A=1-294.
DR   PDB; 7F4E; X-ray; 1.78 A; A=8-294.
DR   PDB; 7F51; X-ray; 1.98 A; A=8-294.
DR   PDBsum; 1Q14; -.
DR   PDBsum; 1Q17; -.
DR   PDBsum; 1Q1A; -.
DR   PDBsum; 1SZC; -.
DR   PDBsum; 1SZD; -.
DR   PDBsum; 2OD2; -.
DR   PDBsum; 2OD7; -.
DR   PDBsum; 2OD9; -.
DR   PDBsum; 2QQF; -.
DR   PDBsum; 2QQG; -.
DR   PDBsum; 7F4E; -.
DR   PDBsum; 7F51; -.
DR   AlphaFoldDB; P53686; -.
DR   SMR; P53686; -.
DR   BioGRID; 36162; 178.
DR   FunCoup; P53686; 557.
DR   IntAct; P53686; 3.
DR   MINT; P53686; -.
DR   STRING; 4932.YPL015C; -.
DR   BindingDB; P53686; -.
DR   ChEMBL; CHEMBL5933; -.
DR   DrugCentral; P53686; -.
DR   iPTMnet; P53686; -.
DR   PaxDb; 4932-YPL015C; -.
DR   PeptideAtlas; P53686; -.
DR   EnsemblFungi; YPL015C_mRNA; YPL015C; YPL015C.
DR   GeneID; 856092; -.
DR   KEGG; sce:YPL015C; -.
DR   AGR; SGD:S000005936; -.
DR   SGD; S000005936; HST2.
DR   VEuPathDB; FungiDB:YPL015C; -.
DR   eggNOG; KOG2682; Eukaryota.
DR   GeneTree; ENSGT00940000157514; -.
DR   HOGENOM; CLU_023643_7_2_1; -.
DR   InParanoid; P53686; -.
DR   OMA; ATHSCID; -.
DR   OrthoDB; 420264at2759; -.
DR   BioCyc; YEAST:G3O-33934-MONOMER; -.
DR   BRENDA; 2.3.1.286; 984.
DR   Reactome; R-SCE-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   SABIO-RK; P53686; -.
DR   BioGRID-ORCS; 856092; 1 hit in 10 CRISPR screens.
DR   CD-CODE; E03F929F; Stress granule.
DR   EvolutionaryTrace; P53686; -.
DR   PRO; PR:P53686; -.
DR   Proteomes; UP000002311; Chromosome XVI.
DR   RNAct; P53686; protein.
DR   GO; GO:0005737; C:cytoplasm; IDA:SGD.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0017136; F:histone deacetylase activity, NAD-dependent; IDA:SGD.
DR   GO; GO:0046970; F:histone H4K16 deacetylase activity, NAD-dependent; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070403; F:NAD+ binding; IBA:GO_Central.
DR   GO; GO:0045950; P:negative regulation of mitotic recombination; IMP:SGD.
DR   GO; GO:0000183; P:rDNA heterochromatin formation; IMP:SGD.
DR   CDD; cd01408; SIRT1; 1.
DR   Gene3D; 3.30.1600.10; SIR2/SIRT2 'Small Domain; 1.
DR   Gene3D; 3.40.50.1220; TPP-binding domain; 1.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR050134; NAD-dep_sirtuin_deacylases.
DR   InterPro; IPR003000; Sirtuin.
DR   InterPro; IPR026591; Sirtuin_cat_small_dom_sf.
DR   InterPro; IPR017328; Sirtuin_class_I.
DR   InterPro; IPR026590; Ssirtuin_cat_dom.
DR   PANTHER; PTHR11085:SF6; NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2; 1.
DR   PANTHER; PTHR11085; NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5, MITOCHONDRIAL-RELATED; 1.
DR   Pfam; PF02146; SIR2; 1.
DR   PIRSF; PIRSF037938; SIR2_euk; 1.
DR   SUPFAM; SSF52467; DHS-like NAD/FAD-binding domain; 1.
DR   PROSITE; PS50305; SIRTUIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Metal-binding; NAD; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Transferase; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..357
FT                   /note="NAD-dependent protein deacetylase HST2"
FT                   /id="PRO_0000110282"
FT   DOMAIN          5..284
FT                   /note="Deacetylase sirtuin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236"
FT   REGION          317..357
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        317..329
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        135
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236,
FT                   ECO:0000269|PubMed:20726530"
FT   BINDING         32..52
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:14502267,
FT                   ECO:0000269|PubMed:15150415"
FT   BINDING         115..118
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:14502267,
FT                   ECO:0000269|PubMed:15150415"
FT   BINDING         143
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236,
FT                   ECO:0000269|PubMed:14502267, ECO:0000269|PubMed:14604530,
FT                   ECO:0000269|PubMed:15150415, ECO:0000269|PubMed:17289592"
FT   BINDING         146
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236,
FT                   ECO:0000269|PubMed:14502267, ECO:0000269|PubMed:14604530,
FT                   ECO:0000269|PubMed:15150415, ECO:0000269|PubMed:17289592"
FT   BINDING         170
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236,
FT                   ECO:0000269|PubMed:14502267, ECO:0000269|PubMed:14604530,
FT                   ECO:0000269|PubMed:15150415, ECO:0000269|PubMed:17289592"
FT   BINDING         173
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236,
FT                   ECO:0000269|PubMed:14502267, ECO:0000269|PubMed:14604530,
FT                   ECO:0000269|PubMed:15150415, ECO:0000269|PubMed:17289592"
FT   BINDING         223..225
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:14502267,
FT                   ECO:0000269|PubMed:15150415"
FT   BINDING         248..250
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:14502267,
FT                   ECO:0000269|PubMed:15150415"
FT   BINDING         270
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:14502267,
FT                   ECO:0000269|PubMed:15150415"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   MUTAGEN         117
FT                   /note="I->A,D,H,W,Y: Nearly or completely catalytically
FT                   inactive."
FT                   /evidence="ECO:0000269|PubMed:17289592"
FT   MUTAGEN         117
FT                   /note="I->F,V: Near wild-type activity for deacetylation.
FT                   Increases slightly the KM for NAD(+) to 25 uM."
FT                   /evidence="ECO:0000269|PubMed:17289592"
FT   STRAND          3..6
FT                   /evidence="ECO:0007829|PDB:1SZD"
FT   HELIX           9..21
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          27..31
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           33..39
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          44..46
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   TURN            47..49
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           51..53
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           56..58
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           63..67
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           69..74
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           77..86
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          88..90
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           95..105
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          109..114
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           120..123
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           128..130
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          131..133
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          136..143
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   TURN            144..146
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           153..159
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          161..163
FT                   /evidence="ECO:0007829|PDB:1SZD"
FT   TURN            171..173
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          176..181
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           191..208
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          210..214
FT                   /evidence="ECO:0007829|PDB:7F51"
FT   STRAND          218..223
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   TURN            229..232
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           233..237
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          242..250
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           254..257
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   STRAND          264..266
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           270..281
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           284..291
FT                   /evidence="ECO:0007829|PDB:1Q1A"
FT   HELIX           304..313
FT                   /evidence="ECO:0007829|PDB:1Q14"
SQ   SEQUENCE   357 AA;  39979 MW;  ED281E5B8241A4D0 CRC64;
     MSVSTASTEM SVRKIAAHMK SNPNAKVIFM VGAGISTSCG IPDFRSPGTG LYHNLARLKL
     PYPEAVFDVD FFQSDPLPFY TLAKELYPGN FRPSKFHYLL KLFQDKDVLK RVYTQNIDTL
     ERQAGVKDDL IIEAHGSFAH CHCIGCGKVY PPQVFKSKLA EHPIKDFVKC DVCGELVKPA
     IVFFGEDLPD SFSETWLNDS EWLREKITTS GKHPQQPLVI VVGTSLAVYP FASLPEEIPR
     KVKRVLCNLE TVGDFKANKR PTDLIVHQYS DEFAEQLVEE LGWQEDFEKI LTAQGGMGDN
     SKEQLLEIVH DLENLSLDQS EHESADKKDK KLQRLNGHDS DEDGASNSSS SQKAAKE
//
